Adolescents in Clinical Trials & the RACE for Children Act

Missy Hansen, MSN, APRN, CPNP, CPHON, Pediatric Strategy Liaison, Center for Pediatric Clinical Development, ICON a former nurse practitioner now working in pediatric clinical development, and Lori Ranney, DNP, APRN, CPNP, CPHON, Children’s Minnesota, a nurse practitioner, discuss the future of pediatric oncology development and treatment options and their experiences treating the adolescent and young adult populations in light of the passage of the RACE (Research to Accelerate Cures & Equity) for Children Act. 

Access the webinar here.

Missy Hansen MSN, APRN, CPNP, CPHON, joined ICON in 2019 as a pediatric strategy liaison. She has 25+ years of experience as a pediatric nurse practitioner, including 17+ years in pediatric hematology/oncology at Children’s Minnesota, the largest hematology/oncology service line in the region, providing care for infants through young adults diagnosed with hematologic and/or oncology conditions. Ms. Hansen gained expertise working in inpatient, outpatient, and urgent care type settings. Ms. Hansen has in-depth experience working with the Children’s Oncology Group—the largest consortium with the most open pediatric studies around the world. She also has experience working with other consortia that conduct trials for pediatric to young adult patients.

Lori Ranney DNP, APRN, CPNP, CPHON, has worked in pediatric oncology for 20 years and has been a PNP at Children’s Minnesota for over 13 years. She has a special interest in leukemia/lymphoma, patient/family education, AYA population, and oncofertility. She is a member of the Children’s Oncology Group and has actively enrolled patients in clinical trials for over 15 years.

Understanding DCTs: Decentralized Clinical Trials

Panelists provide information for patients, patient advocates & the public about what decentralized clinical trials are, how they work, and the importance of diversity in clinical research participation in a 15-minute Flash webinar. Access the webinar recording here.

Adam Samson, Moderator
Sr. Director of Clinical Operations & Customer Success

For over a decade, Adam has conducted clinical trials across multiple therapeutic areas as a research coordinator, monitor, project manager, and director at various types of organizations—investigational sites, CROs, academia, pharma, and tech. He received a master’s in clinical research from The George Washington University. In June 2020, he joined as Director of Clinical Operations at Curebase, a provider of software and services purpose-built for decentralized clinical trials (DCTs), where he is responsible for oversight of DCT services.

Arsheen Ali, Panelist
Clinical Project Manager

Arsheen Ali is a Project Manager and has served in this role with Curebase for over two years. In this capacity, she manages multiple decentralized clinical trials. Her background includes a variety of healthcare and research experience. She received her bachelor’s in integrative biology from UC Berkeley. Arsheen’s main interests are public health (population and community health focus), increasing healthcare quality and access (especially for minority/marginalized populations), and maximizing the efficiency of research.

Myra Lane
Lead Virtual Research Coordinator

Myra Lane is Lead Virtual Research Coordinator at Curebase with over three years of clinical research experience in the decentralized clinical trial space interacting directly with patients. She has worked in various therapeutic areas including neurology, dermatology, and oncology. She is passionate about the impact that the digital therapeutics approach has on addressing unmet patient needs by providing universal access to clinical research and accelerating the development of treatments.

Rare Disease Clinical Trials: How to Prepare for When the Clinical Trial Ends

Part 2 of a 3-part series. Learn about clinical trials, what it means to participate, and what happens when the clinical trial is completed. Moderated by Marsha Lanes of NORD (National Organization for Rare Disorders).

Access the webinar here.

marsha-lanes-200px

Moderator
Marsha Lanes,
Genetic Counselor/
Medical Editor,
NORD

tracy dixon salazar 200px

Panelist
Dr. Tracy Dixon-Salazar,
Executive Director,
Lennox-Gastaut
Syndrome Foundation

Panelist
Richie Kahn, MPH
Senior Director,
Patient Engagement,
Medable Inc.

dana holinka 200px

Panelist
Dana Holinka,
Operating Board Member,
TSC Alliance

PLSP: Plain Language Summaries of Publication

This webinar provides a greater understanding on how Plain Language Summaries of Publication (PLSP) can help meet the demand and expectations for the disclosure of clinical trial results. Additionally, gaining insights on how to plan and turn a scientific manuscript into a PLSP.

Access the webinar here.

Democratizing Clinical Research

Scaling access and inclusion to clinical research is key to finding medications, therapies & treatments that work for all. Industry professionals discuss barriers to clinical trial participation and ways to address them.

Access webinar here.
PRA_Scott Schliebner For Web

Moderator
Scott Schliebner,
SVP Scientific Affairs,
PRA Health Sciences

Headshot of Dr. Teneasha Washington, PhD, MPH (Assistant Professor, Health Behavior), 2020.

Panelist
Teneasha Washington,
PhD, MPH
Assistant Professor,
University of Alabama at Birmingham
School of Public Health
Department of Public Health

Veer Mehta

Panelist
Veer Mehta,
Founder & CEO,
Halo Health Systems

Jennifer Fields

Panelist
Jennifer Fields, MPH
President,
The Hills Tandem

Postpartum Depression (PPD) & Clinical Trials Part 2

Part 2 of a 2-part series. Medical professionals and patient advocates discuss their experiences with postpartum depression, one of the most common medical complications during and after pregnancy.

Access the webinar recording here.
kedwards_ws

Moderator
Kim Edwards,
Senior Manager, Health Communication Services, CISCRP

Dr. Gus Alva

Panelist
Dr. Gus Alva,
Founder & Medical Director,
ATP Clinical Research

Dr. Bassem Maximos

Panelist
Dr. Bassem Maximos,
OB/GYN

Tonya Fulwider

Panelist
Tonya Fulwider,
Associate Director,
Mental Health America
of Ohio

file3

Presenter
Shalome Sine,
Project Manager,
CISCRP

Postpartum Depression (PPD) & Clinical Trials Part 1

Part 1 of a 2-part series. Medical professionals and patient advocates discuss their experiences with postpartum depression, one of the most common medical complications during and after pregnancy.

Access the webinar here.
kedwards_ws

Moderator
Kim Edwards,
Senior Manager, Health Communication Services, CISCRP

Dr. Constance Guille

Panelist
Dr. Constance Guille,
Founder & Director,
Women’s Reproductive Behavioral Health Program, MUSC,
Assoc. Professor,
MUSC

Dr. Jason James

Panelist
Dr. Jason James,
OB/GYN

Heather Dopp

Panelist
Heather Dopp,
Mom Ambassador,
2020 Mom

Building A Clinical Trials Website that Engages Patients & the Public

In this webinar, a speakers from Merck/EMD Serono, TrialScope and CISCRP discuss building a clinical trials website that engages patients and the public.

Robert Janiak, Head of Clinical Trial Transparency, Merck KGaA, Darmstadt, Germany, which operates its healthcare business as EMD Serono in the US and Canada, reviews the launch of a dedicated clinical trials website using the TrialScope Engage™ platform. Jill McNair, Senior Director, Health Communication Services for CISCRP, discusses how CISCRP obtained patient input and how that feedback guided content creation. Naor Chazam, CMO, TrialScope explains how its technology — syncing clinical trial data to the website and generating robust search functionality — helps patients find and enroll in relevant trials, and keep participants informed of study updates and results.

Access the webinar here.

New Patient Engagement Insights from the 2019 CISCRP Perceptions & Insights Study

CISCRP hosted a webinar on October 29, 2019 to share the results of the latest 2019 Perceptions & Insights Study. Over 12,450 people (including 3,600 prior study volunteers) from around the world provided their opinions on clinical research. This latest study reveals significant new insights on patient engagement preferences in particular – such as preferences for learning about clinical trials and services which reduce burden the most, the impact of physician recommendations and involvement in clinical trials, and receptivity to emerging models of clinical trials and new technologies.  Critical differences in sentiments by region, race/ethnicity and other demographic variables will also be explored, along with trends and comparisons to prior studies.   

Topics Discussed:

  • How perceptions of clinical research have changed over the years 
  • Preferred patient engagement initiatives
  • Ways to improve clinical research experiences 

Key Takeaways:

  • Continued acknowledgment of the importance of clinical research, but awareness and trust less among those that have never participated  
  • Healthcare provider recommendations continue to be critical to increasing participation in trials 
  • No one size fits all when it comes to various clinical trial models (traditional vs de-centralized) 
  • Study summary and individual results most wanted post-participation
  • Electronic consent forms viewed as easier to understand compared to paper 

Speakers:

  • Ken Getz, Founder and Board Chair at CISCRP and Deputy Director and Professor at Tufts CSDD Tufts University School of Medicine
  • Annick Anderson, Director of Research Services at CISCRP
  • Jasmine Benger, Senior Project Manager of Research Services at CISCRP

To receive invitations to future CISCRP webinars subscribe to our email list.

To collaborate or host a webinar with CISCRP, please email info@ciscrp.org or call the marketing team at 617-725-2750.